'First-in-class' precision cancer drug shows promising results in Phase I trial
June 25 2020, 08:00
A new drug targeting cancer’s ability to repair its DNA has shown promising results in a Phase I trial.
A new drug targeting cancer’s ability to repair its DNA has shown promising results in a Phase I trial.
Source:
FOX News